Frontlight ResearchEarly access
Taking people in NetherlandsPhase 1
Skin-Injected Immunotherapy Pilot Study for Cervical Cancer Patients
A early-stage study testing an immunotherapy given under the skin in adults with cervical cancer.
Key facts
- Who runs it
- Universitair Medisch Centrum Groningen
- Where
- Groningen, NetherlandsSee the site
- Trial code
- Registry title
- Pilot Study on Subcutaneously Administered Immunotherapy for the Treatment of Cervical Cancer
- Status
- Recruiting
- Phase
- Phase 1
- People taking part
- 12 people, planned
- Started
- 5 Jan 2026
- Expected to end
- 2 Mar 2027
- Type of study
- Interventional
- Record updated
- 19 August 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adult women with cervical cancer. It tests an immunotherapy given as an injection under the skin.
- Age
- 18 years or older
- Sex
- Women only
Where in Netherlands
- Universitair Medisch Centrum GroningenGroningen, NetherlandsTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).
- Plain-language title
- Skin-Injected Immunotherapy Pilot Study for Cervical Cancer PatientsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 9 November 2026.
- Record updated
- 19 August 2025